Comparison of two commercial assays for the characterization of rpoB mutations in Mycobacterium tuberculosis and description of new mutations conferring weak resistance to rifampicin.
about
Molecular patterns of multidrug resistance of Mycobacterium tuberculosis in Georgia.Investigation on Mycobacterium tuberculosis diversity in China and the origin of the Beijing cladeSequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence settingUtility of Line Probe Assay for the Early Detection of Multidrug-Resistant Pulmonary TuberculosisInternational spread of MDR TB from Tugela Ferry, South Africa.Mutation analysis of mycobacterial rpoB genes and rifampin resistance using recombinant Mycobacterium smegmatis.Molecular detection of rifabutin-susceptible Mycobacterium tuberculosisTuberculosis-spoligo-rifampin-isoniazid typing: an all-in-one assay technique for surveillance and control of multidrug-resistant tuberculosis on Luminex devicesSimultaneous identification of mycobacterial isolates to the species level and determination of tuberculosis drug resistance by PCR followed by electrospray ionization mass spectrometry.Mutations in rpoB and katG genes of multidrug resistant mycobacterium tuberculosis undetectable using genotyping diagnostic methods.Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda.
P2860
Q33703858-BB317153-921A-4588-BBF5-0FE3441638CDQ34119100-DB30A07C-935B-49C7-9086-DAE437479D82Q34286080-BC5C873F-28B1-4A7F-B0AF-E63085D4FEEBQ35663357-90C3270E-B3A2-438C-BD21-F7B65AC1983BQ35847213-E4D3B669-5C02-4ABE-89E8-3E260ED1C271Q35867423-989DD39F-FAD1-4AA8-8DE5-B3EAAE30A9A5Q36022900-0AAA3593-69F4-4F97-B141-81409E7682F2Q37470290-5E61ECFB-86A1-4B6F-B578-FFDBEE10F277Q39964636-3FA57C44-C1C5-40E3-A8FB-1FCE54BBA9E0Q41495006-130091D7-76D5-42AD-9E3E-A9FE5C7ADC12Q55260133-EEA1DB92-0BF0-4BE6-9E74-B476AF1FC0BF
P2860
Comparison of two commercial assays for the characterization of rpoB mutations in Mycobacterium tuberculosis and description of new mutations conferring weak resistance to rifampicin.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Comparison of two commercial a ...... weak resistance to rifampicin.
@en
Comparison of two commercial a ...... weak resistance to rifampicin.
@nl
type
label
Comparison of two commercial a ...... weak resistance to rifampicin.
@en
Comparison of two commercial a ...... weak resistance to rifampicin.
@nl
prefLabel
Comparison of two commercial a ...... weak resistance to rifampicin.
@en
Comparison of two commercial a ...... weak resistance to rifampicin.
@nl
P2093
P2860
P356
P1476
Comparison of two commercial a ...... weak resistance to rifampicin.
@en
P2093
Charles Soler
Christine Pourcel
Michel Fabre
Yolande Hauck
P2860
P304
P356
10.2217/14750708.6.2.259
P407
P577
2009-06-11T00:00:00Z